Amicus Blue

Therapeutic Apheresis and Cell Therapy

The Amicus Apheresis System provides a single solution to support your patient’s individual needs. Amicus supports the need for a versatile, multi-procedural instrument with the convenience of a single device.

The precision design and time-tested technology of the Amicus device are the foundation that provides the flexibility to support various therapeutic and collection protocols.

Amicus Blue

One Source Multiple Procedures

seperator line

Therapeutic Plasma Exchange (TPE)

High Plasma removal efficiency, accurate fluid balance control with real-time volume measurement. 
seperator line

Red Blood Cell Exchange (RBCx)

Precision red cell removal for Exchange,Depletion/Exchange, and Depletion procedures.
seperator line

Platelet Collection

High efficiency platelet collection, options for concurrent plasma and RBC collection, and automatic PAS capability.
seperator line

Mononuclear Cell Collection (MNC)

High MNC collection efficiency with low platelet loss, flexible controls allow tailoring of MNC settings for targeted cell content based upon clinical need.
seperator line

Extracorporeal Photopheresis (ECP)

The ECP protocol is an expanded indication for the Amicus ECP System, utilizing Amicus MNC collection technology and the Phelix Photoactivation Device.

Details

Multi-Therapeutic Platform

  • MNC* - High MNC collection efficiency with low platelet loss, flexible controls allow tailoring of MNC settings for targeted cell content based upon clinical need
  • TPE - High plasma removal efficiency, accurate fluid balance control with real-time volume measurement and automatic bag switching for replacement fluid
  • RBCX - Precision red cell removal for Exchange, Depletion/Exchange, and Depletion procedures with low extracorporeal volume (160 mL)
  • ECP** - The ECP protocol is an expanded indication for the Amicus Separator, utilizing Amicus MNC collection technology and the Phelix Photoactivation Device
  • Platelets* - High efficiency platelet collection with options for concurrent plasma, RBC collection and automatic PAS capability

* Platelets and MNC are a collection and not a therapeutic indication.

** The Amicus System for ECP is approved by Health Canada for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment (license #112267).

Focused on Patient and Donor Care

Donor/Patient Focused Technology
Amicus allows fine-tuning of flow rates, regulates citrate return, and can provide saline to the donor or patient throughout a procedure.

Reliable Automation
Designed for medical professionals to support patient and donor needs. Amicus uses a built-in interface detector for fully automated separation.

Safety Controls
Built-in safety control features ensure each procedure is continuously monitored throughout the process. Amicus uses 6 pumps and 5 weigh scales for redundant safety controls.

Designed with Operators In Mind
From start to finish, the color touch screen guides the user by providing prompts throughout the procedure.

Contact your local Fresenius Kabi representative for technical information.

CodeItemQuantity
6R4590Amicus Separator1
6R4590TH-MAmicus Separator - MNC1
6R4590TH-TAmicus Separator - TPE1
6R4582Phelix Photoactivation Device1
X6R2326Amicus MNC Apheresis Kit - Double Needle6 units/case
X6R2349Amicus Exchange Kit - Therapeutics for Therapeutic Plasma Exchange (TPE) & Red Blood Cell Exchange (RBCx)6 units/case
X7R2346Amicus Extracorporeal Photopheresis (ECP) apheresis kit6 units/case
C4B7891XAnticoagulant Citrate Dextrose Solution, USP, Formula A, 1000 mL, DIN 0078813914 units/case

Contact your local Fresenius Kabi representative for full ordering information and accessories, or download the Transfusion and Cell Technologies Product Catalog.